Orchard Capital Managment, LLC Ligand Pharmaceuticals Inc Transaction History

Orchard Capital Managment, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	BUY	$74.52 - $117.06 $141,588 - $222,414	1,900 Added 2.58%	75,496 $6.94 Million
Q1 2022 May 16, 2022	BUY	$94.99 - $151.56 $474,950 - $757,800	5,000 Added 7.29%	73,596 $8.28 Million
Q4 2021 Feb 15, 2022	BUY	$127.69 - $165.85 $165,997 - $215,605	1,300 Added 1.93%	68,596 $10.6 Million
Q2 2021 Aug 17, 2021	BUY	$113.03 - $155.64 $239,171 - $329,334	2,116 Added 3.25%	67,296 $8.83 Million
Q1 2021 May 17, 2021	BUY	$99.52 - $215.83 $622,895 - $1.35 Million	6,259 Added 10.62%	65,180 $9.94 Million
Q4 2020 May 17, 2021	BUY	$80.55 - $106.05 $4.75 Million - $6.25 Million	58,921 New	58,921 $5.86 Million

255

18.1M

26.8K

9.3K

Ticker LGND
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 16,882,800
Market Cap $1.86B
Description
Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, focuses on developing or acquiring technologies that help pharmaceutical companies to discover and develop medicines worldwide. Its commercial programs include Kyprolis and Evomela, which are used to treat multiple myeloma; Veklury for the treatment of moderate or severe COVID-19;...

Get notified when there are updates to the investment portfolio of Orchard Capital Managment, LLC, based on Form 13F filings with the SEC.

Stay updated on Orchard Capital Managment, LLC with notifications on news.